This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

WAS Gene Therapy

Genethon

Drug Names(s): WAS Gene Therapy

Description: Genethon's treatment for Wiskott-Aldrich syndrome consists of autologous CD34+ cells transduced with a lentiviral vector containing the human Wiskott-Aldrich syndrome gene.


WAS Gene Therapy News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug